CMBA
CORT icon

C.M. Bidwell & Associates’s Corcept Therapeutics CORT Stock Holding History

C.M. Bidwell & Associates’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10
Closed -$325 – 493
2023
Q4 		$325 Sell
10
-4,596
-100% -$126K ﹤0.01% 468
2023
Q3 		$125K Buy
+4,606
New +$133K 0.1% 187
2020
Q3 		– Sell
-18,280
Closed -$307K – 467
2020
Q2 		$307K Buy
+18,280
New +$257K 0.28% 74
2020
Q1 		– Sell
-3,710
Closed -$45K – 375
2019
Q4 		$45K Buy
+3,710
New +$51.6K 0.04% 245

Other funds holding CORT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $5.56B AUM 17.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return